APA (7th ed.) Citation
Dymond, A., Martin, P., So, K., Mariani, G., Huang, Y., Severin, P., . . . Lisbon, E. (2017). Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: Results from two clinical trials. European Journal of Clinical Pharmacology, 73(2), 175-185.
Chicago Style (17th ed.) Citation
Dymond, Angela, Paul Martin, Karen So, Gabriella Mariani, Yifan Huang, Paul Severin, David Mathews, and Eleanor Lisbon. "Effects of Cytochrome P450 (CYP3A4 and CYP2C19) Inhibition and Induction on the Exposure of Selumetinib, a MEK1/2 Inhibitor, in Healthy Subjects: Results from Two Clinical Trials." European Journal of Clinical Pharmacology 73, no. 2 (2017): 175-185.
MLA (9th ed.) Citation
Dymond, Angela, et al. "Effects of Cytochrome P450 (CYP3A4 and CYP2C19) Inhibition and Induction on the Exposure of Selumetinib, a MEK1/2 Inhibitor, in Healthy Subjects: Results from Two Clinical Trials." European Journal of Clinical Pharmacology, vol. 73, no. 2, 2017, pp. 175-185.
Warning: These citations may not always be 100% accurate.